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SUMMARY
The epidemiology of osteoporotic fractures varies widely among countries and is primarily 
related to differences in the population and utilization of public healthcare services. Since 1994, 
over 200 studies about osteoporosis and fractures have been conducted in Brazil, among whi-
ch 60 have described the current epidemiological status. This work is a compilation of studies 
published in scientific journals (PubMed, MedLine, Lilacs, SciELO Database) with the respective 
highlights. Overall, these studies show moderate incidence of hip fracture in subjects over 50 
years old. However, the prevalence of all types of bone fragility fracture is higher, ranging from 
11% to 23.8%. In addition, there is a high incidence of recurrent falls, which are the main extra-
skeletal factor associated with these fractures. According to the national studies, 12 months 
after femoral fractures, the mortality rate ranged between 21.5% and 30%, and there was also a 
high rate of physical impairment, deterioration of the quality of life and excessive burden to the 
healthcare system. Considering its high prevalence and associated mortality and physical im-
pairment, osteoporosis and its main consequence, bone fragility fractures, must be considered 
a major public health problem in our country. Arq Bras Endocrinol Metab. 2010;54(2):164-70
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SUMÁRIO
A epidemiologia das fraturas por osteoporose varia amplamente entre os países, principalmen-
te em decorrência das diferenças entre as populações e da utilização de recursos públicos de 
saúde. Desde 1994, mais de 200 estudos sobre osteoporose e fraturas foram feitos no Brasil, 
dos quais 60 descreveram a situação epidemiológica atual. Esse manuscrito é a compilação de 
estudos publicados em revistas científicas (PubMed, MedLine, Lilacs, SciELO Database) com 
seus principais achados. Em geral, esses trabalhos mostram moderada incidência de fratura de 
quadril em indivíduos acima de 50 anos de idade. No entanto, a prevalência de todos os tipos 
de fratura por fragilidade óssea é elevada, variando de 11% a 23,8%. Além disso, é observada 
alta incidência de quedas recorrentes, um dos principais aspectos extraesqueléticos associados 
com essas fraturas. De acordo com os estudos nacionais, 12 meses após a fratura de fêmur, 
a taxa de mortalidade variou de 21,5% a 30%, com elevada taxa de incapacidade física, dete-
rioração da qualidade de vida e grande impacto sobre o sistema de saúde. Diante da elevada 
prevalência, associação com mortalidade e incapacidade física, a osteoporose e sua principal 
consequência, a fratura por fragilidade óssea, deveriam ser consideradas um problema de saú-
de pública em nosso país. Arq Bras Endocrinol Metab. 2010;54(2):164-70
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The incidence of osteoporotic fractures varies wi-dely among countries and is primarily related to 
differences in the population and utilization of public 
healthcare services (Table 1). In Latin America, studies 
have shown a prevalence of hip fracture of 4 to 36.2 
for every 10,000 people (1). However, little is known 
on the epidemiology of osteoporosis and bone fragili-
ty fractures in representative samples of the Brazilian 
population. From 1994 to October 2009, over 200 
national osteoporosis studies have been conducted and 
published in reference scientific journals by PubMed, 
MedLine, Lilacs, SciELO Database, among which 60 
specifically described the epidemiological status of the-
se conditions.
Table 1. Annual hip fracture incidence for every 10,000 inhabitants among 
subjects over 50 in the international scenario
City, Country Year Women Men
Oslo, Norway 1996-1997 118 44
Rochester, United States 1988-1989 114 41
Fune, Denmark 1973-1975 90 30
Wessex, England 1993-1995 82 30
Reikjavik, Iceland 1990-1992 69.7 35
Geneva, Switzerland 1991 65 16
Picardy, France 1987 44 18
Hong Kong, China 1991 42.8 27
La Plata, Argentina 1988-1989 33 26
Budapest, Hungary 1992 31.6 25
Beijing, China 1988-1992 9.6 10.7
Siena, Italy 1975-1985 3 0.7
Table 2. Annual hip fracture incidence for every 10,000 inhabitants among 
subjects over 50 in Brazil
Author/Year Region Women Men
Sisson de Castro, 1990-1992 (2) Porto Alegre, RS 20.2 10.5
Castro da Rocha, 1996-2000 (3) Sobral, CE 20.7 8.9
Silveira, 2001-2002 (4) Fortaleza, CE 27.5 13
Komatsu, 1994-1995 (5) Marília, SP 50 18.7
quantitative, personal household interviews. According 
to data from this piece of research, the prevalence of 
low-impact fractures (humerus, femur, spine, forearm 
and ribs) in subjects over 50 was 12.8% for men and 
15.1% for women (6).
A general study of the population of the state of Rio 
Grande do Sul showed a fracture prevalence of 28.3%, 
predominantly of the upper limbs and feet. The frac-
ture prevalence throughout life was 37.5% in men, re-
sulting primarily from sports and recreational activities 
and 21.3% in women, particularly in association with 
falls at home. It is important to point out that all frac-
tures were included in the study, and not only the low-
impact fractures (7).
The LAVOS (Latin American Vertebral Osteoporosis 
Study) was the first epidemiological study performed in 
Latin America to assess morphometric vertebral frac-
tures and the main risk factors associated. Clark and 
cols. (8), when randomly assessing 1922 women over 
50 from five Latin American countries (Argentina, Bra-
zil, Colombia, Mexico and Porto Rico), found a preva-
lence of morphometric vertebral fractures (11.18; 95% 
CI 9.23-13.4) similar to data from Beijing and some 
regions in Europe. Furthermore, there was no signifi-
cant difference between countries, but vertebral defor-
mities increased with age (from 6.9% at 50-59 to 27.8% 
in women over 80, p < 0.001). Specifically in Brazil, 
the population studied showed a mean prevalence of 
14.8% of morphometric vertebral fractures and 23.8% of 
nonvertebral fractures (excluding feet, hands, skull and 
those resulting from accidents or trauma), including hip 
(2.5%) (8).
Lopes and cols. (9), when assessing 769 elderly 
subjects in the community, have also verified similar 
prevalence of morphometric vertebral fractures among 
women (16.7%; 95% CI 13.3-20.1). In men, the preva-
lence was 21.2% (95% CI 16.6-25.7%) (9). On the 
other hand, Bandeira and cols. (10) found higher prev-
alence of vertebral fractures (37%) in 627 postmeno-
pausal women, of whom 9% had Grade I and 10.9% had 
Grade III. It is important to emphasize that this high 
Some regional studies in Brazil suggest low to mod-
erate incidences of hip fractures in subjects over 50 years 
old (Table 2). The annual age-adjusted incidence rates 
in the cities of Porto Alegre – RS (2), Sobral – CE (3), 
and Fortaleza – CE (4) were approximately four times 
lower than that reported in Caucasian populations of 
the Northern hemisphere. However, in Marília, SP, 
the incidence was higher, especially among women and 
subjects over 70 (5).
BRAZOS (BRAZilian Osteoporosis Study) was the 
first epidemiological study conducted in a representa-
tive sample of Brazilian men and women over 40, with 
the purpose of estimating the prevalence and identify-
ing the main clinical risk factors associated with low-
impact fractures and recurrent falls. Over 2,400 sub-
jects (70% women) from all regions in Brazil, including 
urban and rural populations, and from all social and 
economic levels, were randomly assessed by means of 
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prevalence may be justified by origin from the refer-
ence center of these women and not from the general 
population (10).
More recently, Pinheiro and cols. (11), when study-
ing a large cohort (SAPOS – SAo Paulo Osteoporosis 
Study) including more than four thousand pre and post-
menopausal women in metropolitan São Paulo found a 
history of bone fragility fracture in 11.5% of this popu-
lation, with mean age at event of 65.5 ± 10 years. Ver-
tebral fractures were reported by 6% of the women and 
nonvertebral fractures were reported by 86%, includ-
ing humerus, forearm, metacarpus, metatarsus, ribs and 
hips. Femur fractures were reported by 8% and a history 
of hip fracture after 50 years of age in first-degree rela-
tives was reported by 15% of the women, particularly by 
those with previous fracture (p < 0.001) (11).
BOne DenSITY AnD OSTeOpOROSIS
The prevalence of osteopenia and osteoporosis shown 
in Brazilian studies is widely variable because of dif-
ferent sample sizes, eligibility criteria and methodolo-
gies (Table 3). Most of these studies used convenience 
samples and populations from tertiary health institu-
tions. SAPOS cohort found osteoporosis in 33% of the 
women, according to bone densitometry findings (11).
there was a high rate of low-impact fractures. Therefore, if 
we adopt the definition of osteoporosis (12) in which the 
diagnosis of established osteoporosis can be determined 
in the presence of low-impact fractures, we will have at 
least 12.8% of osteoporosis in men and 15.1% in women.
Martini and cols. (13), when analyzing data from 
VIGITEL (chronic diseases risk and protection factor 
surveillance by phone, a program under the Ministry of 
Health), described the prevalence of osteoporosis re-
ported by 54,369 adult subjects, both male and female, 
from all the state capitals and the Federal District, as well 
as the main risk and protection factors associated. In 
2006, the frequency of osteoporosis reported was 4.4%, 
predominantly among women (7% vs. 1.3%). Reports of 
osteoporosis increased significantly with age (from 5.2% 
between 45 and 54 to 32.7% in women over 65) (13). 
It is important to highlight that the data presented are 
approximate prevalence based only on the medical diag-
nosis of osteoporosis reported by the subjects, which is 
more representative of the access to healthcare services 
than of the actual prevalence of the disease.
RISK fACTORS
Overall, the clinical risk factors found in Brazilian stud-
ies (6,8,11,13-16) are similar to those observed in the 
international scenario. The main clinical risk and pro-
tection factors associated with low bone density and 
bone fragility fractures, according to national data, are 
presented in Table 4.
Genetic and dietary factors have been associated 
with increased risk of osteoporosis and fractures. Some 
national studies have investigated the genetic poly-
morphism of collagen 1 a1 (COL1A1) (17), a recep-
tor of vitamin D (VDR) (18-21) and estrogen (ERa) 
(22), but did not demonstrate any significant associa-
tion with bone density or fractures. The only national 
epidemiological study showing an association between 
dietary aspects and low-impact fractures was the BRA-
ZOS study (6,23) (Table 5).
Several recent works have pointed to a higher preva-
lence of hypovitaminosis D in all continents, genders, 
age ranges and social and economic levels. Hypovita-
minosis D was also observed among noninstitutional-
ized elderly subjects in the city of São Paulo, especially 
during the winter and fall. Vitamin D deficiency oc-
curred in 15.4% of patients, insufficiency in 41.9% and 
secondary hyperparathyroidism in 55% (24), although 
the relationship between these conditions and the frac-
tures was not investigated by the authors.
Table 3. Low bone density prevalence according to Brazilian studies
population Osteopenia Osteoporosis Author
Premenopausal 22% 6% Martini and cols. (13)
Postmenopausal 38% to 56.6%
30%
33.6%
14.7% to 43.4%
33%
33.8%
Lanzillotti and cols. (14)
Martini and cols. (13)
Clark and cols. (8)
Men 44.6% 15.4% Zerbini and cols. (15)
Elderly
Men
Women
33.3% to 57.4%
36.6% to 56.5%
6.4% to 16.1%
22.2% to 33.2%
Rodrigues Camargo  
and cols. (16)
The incidence of osteoporosis and osteopenia 
among women in the Brazilian sample of the epide-
miological study LAVOS (8), recruited in metropoli-
tan Vitória and Vila Velha, ES by randomized sample 
planning was 33.6% and 33.8%, respectively, according 
to the densitometric criteria proposed by the World 
Health Organization in 1994 (12).
The national epidemiological study (BRAZOS) 
showed that 6% of the general adult population knew 
about the diagnosis of osteoporosis (6). However, since 
no bone densitometry scans were performed, this low 
prevalence is not likely to reflect the reality. Additionally, 
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Table 5. Daily intake of nutrients associated with bone health, according to 
the presence of low-impact fracture
Daily dietary 
intake
Bone fragility fracture
no Yes
Men Women Men Women
Energy (kcal) 1331a
(610-3098)
1197
(427-3565)
1199
(405-5128)
1331
(610-3098)
Protein (g) 62
(51-73)
59
(49-68)
66
(50-76)
60
(53-71)
Calcium (mg) 359
(255-503)
372
(276-518)
382
(263-545)
414*
(296-591)
Phosphorus 
(mg)
737
(632-871)
730
(640-848)
760
(665-882)
772*
(662-934)
Magnesium (mg) 201
(161-245)
189
(158-223)
244
(159-244)
196*
(164-235)
Vitamin D (μg) 1,8
(0,8-2,9)
1,9
(1,1-3,2)
1,6
(0,9-3,1)
2,2
(1,2-3,6)
Vitamin K (μg) 41
(29-64)
43
(34-74)
42
(29-75)
39
(31-71)
Vitamin A (μg 
REA)
131
(18-265)
138
(68-257)
212
(116-335)
231
(141-376)
a median (minimum-maximun). REA: retinol equivalent activity. * Oneway ANCOVA, adjusted for 
age and use of nutritional supplements, p < 0.05 male vs. female with fracture.
Table 4. Clinical risk and protection factors associated with osteoporosis 
and fractures, according to main Brazilian studies
Study Osteoporosis fracture
BRAZOS (6)
Women
Men
Risk: Advanced age, family 
history of femur fracture, early 
menopause, lack of physical 
activity, lower quality of life, 
high phosphorus 
consumption, diabetes 
mellitus, current use of 
benzodiazepines and recurrent 
falls within the previous year
Risk: Lower quality of life, 
current use of tobacco, 
diabetes mellitus and lack of 
physical activity
LAVOS (8) Risk: reported loss of height 
and previous fracture
Protection: hormone 
replacement therapy and 
physical activity 
Lopes and 
cols. (9)
Women
Men
Risk: age and femur neck bone 
density
Risk: recurrent falls and femur 
neck bone density
SAPOS (11) Risk: advanced age, 
menopause, previous fracture 
and current use of tobacco
Protection: high BMI, regular 
physical activity and current 
hormone replacement 
therapy
Risk: advanced age, 
menopause, family history of 
hip fracture and low bone 
density
Protection: regular physical 
activity
VIGITEL (13)
Women
Men
Risk: age over 45 and use of 
tobacco
Protection: higher education 
level, non-Caucasian, regular 
consumption of milk, green 
and yellow vegetables
Risk: age over 65 and lack of 
physical activity
SAPOS: SAo Paulo Osteoporosis Study; BRAZOS: BRAZilian Osteoporosis Study; LAVOS: Latin 
America Vertebral Osteoporosis Study; VIGITEL: Chronic diseases risk and protection factors 
surveillance by phone.
falls
As the population ages, falls represent an ever increasing 
impact on the public healthcare system. Approximately 
30% of the elderly fall every year and nearly half of them 
have recurrent events. However, the incidence of falls 
varies widely and depends on different parameters of the 
population under study, such as gender, age range, ge-
netic factors, life habits and personal background. The 
individual impact of each of these parameters has not 
yet been fully described, but they can be cumulative and 
increase the risk of serious and tragic outcomes in the 
lives of the elderly, particularly cranioencephalic trauma, 
hospitalization, institutionalization, fractures and death.
Falls are associated with vertebral and non-vertebral 
fractures, especially of the hips, regardless of bone den-
sity. The combination of risk factors, bone density and 
falls is relevant for determination of the individual frac-
ture risk of each patient, and also increases the sensitiv-
ity and specificity of instruments used for identifying 
subjects with fractures in population studies. The strat-
egies currently used to prevent osteoporotic fractures 
must fully contemplate these aspects.
In Brazil, the prevalence of recurrent falls within the 
previous 12 months may vary from 10% to 40% (25-33) 
(Table 6). The prevalence may also vary according to 
the region (30) (Figure 1). Overall, the incidence of re-
current falls among subjects in the South is lower than 
that among subjects in other regions. Recurrent falls 
among men from rural regions is significantly higher 
than in metropolitan areas (16.3 and 13.1, respec-
tively). However, this finding was not observed among 
women (24.5% and 25.5%, respectively).
The main clinical risk factors associated with falls 
identified in Brazilian studies were dementia (25), de-
lirium (26), current use of calcium channel blockers, 
benzodiazepines (27,28), physical household environ-
ment (29), advanced age, regular alcohol consumption, 
lower quality of life, previous fracture, diabetes mellitus, 
lower dietary consumption of vitamin D and lack of 
physical activity (30).
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was 21.5% (36). Most of deaths (55.1%) occurred af-
ter medical discharge, especially due to cardiovascu-
lar events and infections (37-38). Recently, Fortes 
and cols. (39) showed a mortality rate of 23.2% after 
6-month follow-up of hip fractures in 56 elderly pa-
tients. Furthermore, they showed that only 30% of pa-
tients were able to return to their previous activities and 
11.6% became completely dependent (39).
Quality of life
Osteoporosis has a significant deleterious impact on the 
quality of life of patients, particularly after bone fragility 
fractures. However, the study conducted by Cantarelli 
and cols. (40) did not demonstrate deterioration of the 
quality of life as assessed by OPAQ (Osteoporosis As-
sessment Questionnaire) in elderly women with osteo-
porosis or low-impact fractures (40).
On the other hand, Lemos and cols. (41) found 
a significant correlation between general (SF-36, The 
Medical Outcomes Study 36 – Item Short Form Health 
Survey) and specific (OPAQ) quality of life question-
naires applied to 40 women with postmenopausal os-
teoporosis, especially for pain, social aspects and mental 
health domains (41).
Costs
Osteoporosis-related costs vary widely among differ-
ent countries, not only due to different incidence rates 
of the disease but also to the emphasis placed on pre-
vention, hospitalization and treatment. Among post-
menopausal women with osteoporosis, the utilization 
of health resources and the annual osteoporosis treat-
ment costs were equivalent to 775 dollars per patient, 
and the drug-related costs required 9% of the monthly 
family income (42). Direct costs with hospitalization 
for osteoporotic hip fractures in subjects over 50 ad-
mitted into private hospitals were 12 thousand dollars, 
mainly related to medical and surgical instrumentation 
(61%). Femur fractures were observed in 4.99% of the 
total 129,611 osteoporosis cases managed by the na-
tional supplementary healthcare system, with a mean 
stay of 9.21 days. The annual economic impact of these 
fractures for health insurance companies was estimated 
at approximately 6 million dollars (43). Although ex-
tremely relevant, these findings do not provide consis-
tent inputs about total mid-term and long-term costs. In 
Latin America, including São Paulo, direct costs of hip 
fractures range between 4.5 and 6 thousand dollars (1).
Table 6. Prevalence of falls, according to the results of Brazilian studies
Author/Year City
falls 
within the 
previous 
12 
months
Recurrent 
falls 
within the 
previous 
year
Chaimowicz and cols., 2000 (27) Belo Horizonte 17% -
Perracini and Ramos, 2002 (31) São Paulo 29% 12%
Schwartz and cols., 1999 (32) São Paulo 29% 12.2%
Rozenfeld and cols., 2003 (33) Rio de Janeiro 37% 14%
Pinheiro and cols., 2008 (30) Brazil
Men
Women
27.1%
32.8%
15.5%
25.6%
Mortality
It is known that 15% to 30% of the patients with hip 
fractures die during the first year after the event, usually 
due to fracture complications such as infection, venous 
thrombosis and pressure ulcers, or associated condi-
tions, especially cardiovascular diseases. In addition, 
these patients have an increased risk of becoming de-
pendent or institutionalized after the fracture. The main 
factors related to the increased risk of death in these 
subjects are related to male gender, advanced age, lower 
functional capacity before the event, higher number of 
concomitant diseases, sarcopenia and frail phenotype 
(34). A recent prospective cohort with a 5-year follow-
up has shown clear association between lower bone mass 
and higher overall and cardiovascular mortality among 
elderly women, regardless of age, which suggests some 
similarity between vascular calcification and atheroscle-
rosis with osteogenesis and osteoporosis (35).
In the first year after hip fractures, the overall mor-
tality observed in a study performed in Rio de Janeiro 
*p < 0,05
(18.3%)
(28.1%)
figure 1. Frequency distribution of falls referred by Brazilian men and 
women over 40 years old by region.
(20.5%)
(19%)
(17.5%)
(8.6%)*
(35.7%)*
(27.9%)
(26.7%)
(14.9%)*
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fInAl COnSIDeRATIOnS AnD COnClUSIOn
An important strategy for implementation of health 
education and promotion-related measures is to know 
the prevalence, incidence and specific risk factors of the 
Brazilian population. Particularly, in Brazil, the main 
clinical risk factors associated with osteoporotic frac-
tures were not known and were usually extrapolated 
from European and American studies. In view of the 
studies presented, the identification and inclusion of 
these risk factors in routine medical practice may facili-
tate evaluation of the risk of fractures as well as indi-
vidualized decision-making.
Using a combination of clinical risk factors and bone 
density measurements, Kanis and cols. (44) have recent-
ly proposed the use of FRAXTM as an objective and use-
ful tool for quantification of the likelihood of fractures 
within the following 10 years, which directly impacts 
the decision-making process and the osteoporosis-relat-
ed costs (44). However, calculation of the absolute risk 
of fractures depends on the population studied, and the 
use of this tool has not yet been approved in Brazil, 
once there is no reference database available (45).
Despite the many treatments available for preven-
tion and management of osteoporosis, with effective 
reduction of vertebral (50% to 65%) and non-vertebral 
(25% to 40%) fractures, most of the Brazilian popula-
tion still has no access to early diagnosis or appropriate 
therapeutics for the disease (34,39,46). Practical mea-
sures for minimization of the risk of fractures can be 
easily implemented by a multidisciplinary team of phy-
sicians, physical educators, nutritionists, physical thera-
pists and psychologists.
Considering its high prevalence and associated 
mortality and physical impairment, osteoporosis and 
its main consequence, bone fragility fractures, must be 
considered a major public health problem in our coun-
try. Public health policies must consider the results of 
the national studies presented before establishing pre-
vention measures and strategies for early management 
of the disease as well as for utilization and allocation of 
financial resources, with a view to minimize the direct 
and indirect costs related to osteoporotic fractures.
In order to prepare the country for the economic 
and social costs that will be and have been imposed by 
osteoporosis on the Brazilian society, additional pro-
spective epidemiological data is required, among other 
data, to allow assessment of the impact of each of the 
risk factors identified in our population as determinants 
of the incidence of different types of fractures. This will 
allow a better pharmacoeconomic understanding of the 
treatments currently approved for osteoporosis in our 
society. We will also be able to define intervention cri-
teria based on the absolute risk of fractures. A group 
of Brazilian investigators and experts are currently de-
signing a broad epidemiological study of osteoporosis 
and bone fragility fractures to provide the country with 
such relevant information.
Disclosure: no potential conflict of interest relevant to this article 
was reported.
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